home
companies
disclaimer
med safety app
FABRAZYME® 5 mg
Powder for solution for infusion
scheduling status
S4
registration number
46/31/0583
What FABRAZYME® 5 mg contains
Contains a nominal value of 5 mg of agalsidase beta.
other ingredients
Mannitol Sodium phosphate.
Therapeutic classification
A16AB04.
Download Patient Info Leaflet
Download Professional Info
© 2026 SAHPRA. ALL RIGHTS RESERVED